Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Women's Heart Attack Research Program: Stress Ancillary Study

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy

Wellness Initiative at New York University

A Natural History Study of Canavan Disease

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial)

AdaptResponse Clinical Trial

MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients

Lifestyle Management of CKD in Obese Diabetic Patients

Regional Versus General Anesthesia for Promoting Independence After Hip Fracture

Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease

OPTIMIZE IDE for the Treatment of ACS

A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

Diabetes CKD Lifestyle Technology Study

Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure

RNS® System Epilepsy PAS

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

HeadStart4: Newly Diagnosed Children (

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Early Feasibility Study of the AccuCinch® Ventricular Repair System - The CorCinch-FMR Study

Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

VY-AADC02 for Parkinson's Disease With Motor Fluctuations

Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis

Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography

Discharge Educational Strategies for Reduction of Vascular Events

Parkinson's Foundation Quality Improvement Initiative

Craniomaxillofacial Allotransplantation

Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation

Entyvio (Vedolizumab) Long Term Safety Study

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

RESOLUTE ONYX Post-Approval Study

Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects

Women's Heart Attack Research Program- Imaging Study

Women's Heart Attack Research Program: Platelet Sub-Study (HARP)

BioVentrix Revivent TC™ System Clinical Study

An Open-label Treatment Protocol for VTS-270 in Patients With Neurologic Manifestations of NPC

Randomized Trial to Assess PO Versus IV Antibiotics

A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers

Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma

Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis

The Safety and Tolerability of Kinetin, in Patients With Familial Dysautonomia

Mobile Decision Support System for Nurse Management of Neuromodulation Therapy

A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)

Neurotrack Test Validation Protocol

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

An Investigational Immuno-therapy Study of Nivolumab or Placebo in Patients With Resected Esophageal or Gastroesophageal Junction Cancer

Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?

Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Aerobic Exercise and Aphasia Treatment

Generalized Seizure Detection And Alerting In The EMU With The Empatica Embrace Watch And Smartphone-Based Alert System

Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a